Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA4 | P22748 | 3/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | RORC | P51449 | 5/20 | 0.32 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.32 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25419381 | 0.83 | SLC22A12 (0.40) | ARCA2CA4PTGS2HSD11B1 | |
| SCHEMBL25418976 | 0.68 | HSD11B1 (0.38) | ARCA2PTGS2HSD11B1CA1 | |
| SCHEMBL25420282 | 0.64 | KIF11 (0.53) | CA2CA4PTGS2SLC6A4CA1 | |
| SCHEMBL31028738 | 0.59 | KDM4E (0.40) | CA2CA4PTGS2SLC6A4CA1 | |
| SCHEMBL31028676 | 0.56 | PTGS2 (0.45) | CA2CA4PTGS2CA1CA5A | |
| SCHEMBL9684079 | 0.56 | CA2 (0.63) | CA2CA4CA1CA5ACA9 | |
| SCHEMBL4715833 | 0.56 | IDO1 (0.51) | SLC6A4 | |
| SCHEMBL31248059 | 0.55 | MPO (0.42) | SLC6A4 | |
| SCHEMBL19926527 | 0.55 | MPO (0.42) | SLC6A4 | |
| SCHEMBL4718190 | 0.54 | MPO (0.44) | SLC6A4CA5ACA9CA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023094830-A1 | SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS | LARIO THERAPEUTICS LIMITED (GB) | 2023-06-01 | — | — | WO | disclosed |